{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:46:38Z","timestamp":1777445198053,"version":"3.51.4"},"reference-count":34,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CB06\/07\/1036"],"award-info":[{"award-number":["CB06\/07\/1036"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"DOI":"10.3389\/fphys.2017.00039","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T22:52:57Z","timestamp":1485816777000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Inhibition of Intermediate-Conductance Calcium-Activated K Channel (KCa3.1) and Fibroblast Mitogenesis by \u03b1-Linolenic Acid and Alterations of Channel Expression in the Lysosomal Storage Disorders, Fabry Disease, and Niemann Pick C"],"prefix":"10.3389","volume":"8","author":[{"given":"Aida","family":"Oliv\u00e1n-Viguera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Lozano-Gerona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"L\u00f3pez de Frutos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge J.","family":"Cebolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Ir\u00fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Abarca-Lachen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana J.","family":"Garc\u00eda-Malinis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel Luis","family":"Garc\u00eda-Ot\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Gilaberte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Giraldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,1,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/ejlt.200700220","article-title":"Argan oil: occurrence, composition and impact on human health","volume":"110","author":"Charrouf","year":"2008","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.bbrc.2016.01.152","article-title":"Role of protein kinase A and class II phosphatidylinositol 3-kinase C2\u03b2 in the downregulation of KCa3.1 channel synthesis and membrane surface expression by lyso-globotriaosylceramide","volume":"2470","author":"Choi","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B3","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.bbrc.2015.11.050","article-title":"Lyso-globotriaosylceramide downregulates KCa3.1 channel expression to inhibit collagen synthesis in fibroblasts","volume":"468","author":"Choi","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1161\/ATVBAHA.113.302200","article-title":"Globotriaosylceramide induces lysosomal degradation of endothelial KCa3.1 in fabry disease","volume":"34","author":"Choi","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1080\/19336950.2015.1071748","article-title":"Pharmacological gating modulation of small- and intermediate-conductance Ca(2+)-activated K(+) channels (KCa2.x and KCa3.1)","volume":"9","author":"Christophersen","year":"2015","journal-title":"Channels (Austin)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1124\/mol.114.093286","article-title":"New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1","volume":"86","author":"Coleman","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"B7","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/jn\/128.9.1411","article-title":"Importance of dietary gamma-linolenic acid in human health and nutrition","volume":"128","author":"Fan","year":"1998","journal-title":"J. Nutr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-immunol-032414-112212","article-title":"Ion channels in innate and adaptive immunity","volume":"33","author":"Feske","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1002\/jcp.24924","article-title":"Functional role of the KCa3.1 potassium channel in synovial fibroblasts from rheumatoid arthritis patients","volume":"230","author":"Friebel","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12863-015-0267-z","volume":"6","author":"Gervas-Arruga","year":"2015","journal-title":"BMC Genet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"16690","DOI":"10.1074\/jbc.M212959200","article-title":"Molecular localization of the inhibitory arachidonic acid binding site to the pore of hIK1","volume":"278","author":"Hamilton","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/MNH.0000000000000083","article-title":"KCa3.1: a new player in progressive kidney disease","volume":"24","author":"Huang","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e112081","DOI":"10.1371\/journal.pone.0112081","article-title":"Modulation of KCa3.1 channels by eicosanoids, omega-3 fatty acids, and molecular determinants","volume":"9","author":"Kacik","year":"2014","journal-title":"PLoS ONE"},{"key":"B14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/0014-5793(92)80319-C","article-title":"Both membrane stretch and fatty acids directly activate large conductance Ca2+-activated K+ channels in vascular smooth muscle cells","volume":"297","author":"Kirber","year":"1992","journal-title":"FEBS Lett."},{"key":"B15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/bs.apha.2016.04.002","article-title":"Endothelial small- and intermediate-conductance K channels and endothelium-dependent hyperpolarization as drug targets in cardiovascular disease","volume":"77","author":"K\u00f6hler","year":"2016","journal-title":"Adv. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1093\/rheumatology\/ker119","article-title":"Evidence for the efficacy of complementary and alternative medicines in the management of rheumatoid arthritis: a systematic review","volume":"50","author":"Macfarlane","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"26691","DOI":"10.1074\/jbc.274.38.26691","article-title":"Mechano- or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel","volume":"274","author":"Maingret","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fphys.2012.00245","article-title":"Effects of n-3 polyunsaturated fatty acids on cardiac ion channels","volume":"3","author":"Moreno","year":"2012","journal-title":"Front. Physiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/bcpt.12092","article-title":"Alterations of N-3 polyunsaturated fatty acid-activated K2P channels in hypoxia-induced pulmonary hypertension","volume":"113","author":"Nielsen","year":"2013","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1016\/j.ymgme.2014.12.198","article-title":"Reduced KCa3.1 channels functions in monocytes\/macrophages in Gaucher disease","volume":"114","author":"Oliv\u00e1n-Viguera","year":"2015a","journal-title":"Mol. Genet. Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/mol.114.095745","article-title":"A novel pan-negative-gating modulator of KCa2\/3 channels, the fluoro-di-benzoate, RA-2, inhibits EDH-type relaxation in coronary artery and produces bradycardia in vivo","volume":"87","author":"Oliv\u00e1n-Viguera","year":"2015b","journal-title":"Mol. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e58614","DOI":"10.1371\/journal.pone.0058614","article-title":"Novel phenolic inhibitors of small\/intermediate-conductance Ca(2)(+)-activated K(+) channels, KCa3.1 and KCa2.3","volume":"8","author":"Olivan-Viguera","year":"2013","journal-title":"PLoS ONE"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e85244","DOI":"10.1371\/journal.pone.0085244","article-title":"The K+ channel KCa3.1 as a novel target for idiopathic pulmonary fibrosis","volume":"8","author":"Roach","year":"2013","journal-title":"PLoS ONE"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13069-015-0022-0","article-title":"Human lung myofibroblast TGF\u03b21-dependent Smad2\/3 signalling is Ca2+-dependent and regulated by KCa K+ channels","volume":"8","author":"Roach","year":"2015","journal-title":"Fibrogenesis Tissue Repair."},{"key":"B25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12931-014-0155-5","article-title":"Increased constitutive inverted question markSMA and Smad2\/3 expression in idiopathic pulmonary fibrosis myofibroblasts is K Ca 3.1-dependent","volume":"15","author":"Roach","year":"2014","journal-title":"Respir. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/gkp045","article-title":"Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data","volume":"37","author":"Ruijter","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1124\/mol.108.051425","article-title":"Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure","volume":"75","author":"Sankaranarayanan","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.fct.2012.01.001","article-title":"Comparison of growth, serum biochemistries and n-6 fatty acid metabolism in rats fed diets supplemented with high-gamma-linolenic acid safflower oil or borage oil for 90 days","volume":"50","author":"Tso","year":"2012","journal-title":"Food Chem. Toxicol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1124\/pr.57.4.9","article-title":"International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels","volume":"57","author":"Wei","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/ane.12034","article-title":"Polyunsaturated fatty acids in multiple sclerosis therapy","volume":"195","author":"Wergeland","year":"2012","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"B31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/FJC.0b013e318279ba20","article-title":"Endothelial small-conductance and intermediate-conductance KCa channels: an update on their pharmacology and usefulness as cardiovascular targets","volume":"61","author":"Wulff","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.1073\/pnas.97.14.8151","article-title":"Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant","volume":"97","author":"Wulff","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1021\/cr078234p","article-title":"K+ channel modulators for the treatment of neurological disorders and autoimmune diseases","volume":"108","author":"Wulff","year":"2008","journal-title":"Chem. Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.pharmthera.2013.10.010","article-title":"Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease","volume":"141","author":"Yates","year":"2014","journal-title":"Pharmacol. Ther."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphys.2017.00039\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T23:33:46Z","timestamp":1568763226000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphys.2017.00039\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,31]]},"references-count":34,"URL":"https:\/\/doi.org\/10.3389\/fphys.2017.00039","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,31]]}}}